New Delhi: Keeping in mind the safety of patients, the central government has taken a major decision. From now on, you won't find many of the medicines you used in the market. It is known that the government has issued an immediate ban on the production, sale and distribution of 16 fixed dose combination (FDC) medicines (Medicines Banned).

Banned drugs include antibiotics, stomach pain medications, diabetes medications, and certain cosmetics and skin medications. The Center has taken this step under Section 26 of the Drugs and Cosmetics Act, 1940. According to government sources, a review by the expert committee Drugs Technical Advisory Board (DTAB) and its sub-committees found no scientific justification for combining these drugs.

Also, there is not enough scientific data to prove their effectiveness. The review process for prohibited drugs started in 2021. During that time various scientific studies, medical data and clinical data were analyzed.

Concerned pharmaceutical companies and other parties were also given an opportunity to express their views. But the expert committee was not satisfied with their arguments. Later in December 2024, the sub-committee recommended banning of these 16 drug combinations.

The most frequently asked questions about antibiotic drugs include several antibiotic combinations such as Amoxicillin and Serratiopeptidase, Amoxicillin and Serratiopeptidase, Lactobacillus Sporogenes, Cefuroxime and Serratiopeptidase and Cefadroxyl + Probenecid. According to experts, no clear medical benefit of using multiple ingredients together has been proven in these cases. Stomach ache and diabetes medicines also banned The government has also banned combinations of medicines for stomach ache and colic like Dicyclomine + Paracetamol + Clidinium Bromide.

Also, the combination of diabetes drug Gliclazide + Chromium Picolinate has been banned. According to experts, there is no recognized international or national medical guidelines recommending the use of Chromium Picolinate in the treatment of diabetes. Safety of patients is the main goal central government says, use of drugs must be based on scientific evidence and medical need.

Any drug combination, which does not provide additional benefit to patients but may increase potential risks, should not be placed on the market. According to the government, this decision is an important step towards safe and rational use of medicines.